Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Erbb2 her2"'
Autor:
Nivedha Murali Shankar, Paola Ortiz-Montero, Anastasia Kurzyukova, Wiebke Rackwitz, Stephan R. Künzel, Winfried S. Wels, Torsten Tonn, Franziska Knopf, Jiri Eitler
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Natural killer (NK) cells are attractive effectors for adoptive immunotherapy of cancer. Results from first-in-human studies using chimeric antigen receptor (CAR)-engineered primary NK cells and NK-92 cells are encouraging in terms of efficacy and sa
Externí odkaz:
https://doaj.org/article/ffb0dee5b8bf4f79b3022bb7448c7718
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Breast cancer arises as a result of multiple interactions between environmental and genetic factors. Conventionally, breast cancer is treated based on histopathological and clinical features. DNA technologies like the human genome microarray are now
Externí odkaz:
https://doaj.org/article/9c2ac3ab191e43bd9cf0d3d45672603a
Autor:
Carmen Miano, Donatella Romaniello, Martina Mazzeschi, Alessandra Morselli, Silvia Da Pra, Francesca Sacchi, Chiara Bongiovanni, Michela Sgarzi, Elvira Pantano, Mattia Lauriola, Gabriele D’Uva
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ERBB4 is a tyrosine kinase receptor reported to exert both oncogenic and tumor suppressor activities. These paradoxical effects were suggested to stem from different ERBB4 homo-/hetero-dimers and/or isoforms. By stratifying breast cancer patients for
Externí odkaz:
https://doaj.org/article/923917465bdb47bcad0432af15021d84
Publikováno v:
NeuroQuantology. 19:20-26
Background: meningioma is considered a common benign tumor and more frequent happen, they are slow growing primary tumors that originate from meningothelial cells of the arachnoid and spinal cord. The histological grade of the WHO and the extension o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3723da3741eb8e930b846e1de7c74584
https://doi.org/10.14704/nq.2021.19.8.nq21108
https://doi.org/10.14704/nq.2021.19.8.nq21108
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Saudi Pharmaceutical Journal, Vol 29, Iss 7, Pp 656-669 (2021)
Breast cancer arises as a result of multiple interactions between environmental and genetic factors. Conventionally, breast cancer is treated based on histopathological and clinical features. DNA technologies like the human genome microarray are now
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c213459ce9dacb124a1a326da8217633
https://doi.org/10.1016/j.jsps.2021.04.027
https://doi.org/10.1016/j.jsps.2021.04.027
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yosr Bouhlal, Soo-Ryum Yang, Anna Vilborg, Francisco M. De La Vega, Calvin J. Kuo, Kimberly H. Allison, Greg Jensen, Morgan Ballard
Publikováno v:
Modern Pathology. 33:1546-1556
In patients with invasive breast cancer, fluorescence in situ hybridization (FISH) testing for HER2 typically demonstrates the clear presence or lack of ERBB2 (HER2) amplification (i.e., groups 1 or 5). However, a small subset of patients can present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d05b2af7a05f91a0f165531ea6b706
https://doi.org/10.1038/s41379-020-0504-5
https://doi.org/10.1038/s41379-020-0504-5
Autor:
Jamie M. Keck, Brian J. Druker, Christopher A. Eide, Shannon K. McWeeney, Elie Traer, Sunil K. Joshi, Cristina E. Tognon, Daniel Bottomly, Jeffrey W. Tyner
Publikováno v:
Leukemia. 34:2798-2804
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87f7c18876310473efb1a612c903ea09
https://doi.org/10.1038/s41375-020-0844-7
https://doi.org/10.1038/s41375-020-0844-7
Autor:
Virginia Espina, Ying Cao, Joyce O'Shaughnessy, Lea Krekow, Jeffrey S. Ross, Lance A. Liotta, Cynthia Osborne, Maren K. Levin, Frankie A. Holmes, Sohail Balasubramanian, Kristi McIntyre
Publikováno v:
JCO Precision Oncology. :1-26
PURPOSE To identify proteomic and genomic alterations in residual disease (RD) for human epidermal growth factor receptor 2 (HER2)-positive (HER2+) breast cancer (BC) after preoperative trastuzumab (H), lapatinib (L), or both (H+L) in combination wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f96e180488281746a9fcdc7a596698c
https://doi.org/10.1200/po.18.00292
https://doi.org/10.1200/po.18.00292
Autor:
Shubham Pant, Funda Meric-Bernstam, Vivek Subbiah, Kenna M. Shaw, Kenneth R. Hess, Xiaofeng Zheng, Kavitha Balaji, Jaffer A. Ajani, Mark J. Routbort, Scott Kopetz, Mariela Blum-Murphy, Kanwal Pratap Singh Raghav, Russell Broaddus, Mehmet Esat Demirhan, Milind Javle, David S. Hong, Apostolia Maria Tsimberidou, Jordi Rodon, Sarina Anne Piha-Paul, Ecaterina Ileana Dumbrava
Publikováno v:
JCO Precision Oncology. :1-12
PURPOSE Human epidermal growth factor receptor 2 (HER2) is an effective therapeutic target in breast and gastric and gastroesophageal junction cancers. However, less is known about the prevalence of ERBB2 ( HER2) amplification and the efficacy of HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23695bf770675dc1e0f145dc91472c4f
https://doi.org/10.1200/po.18.00345
https://doi.org/10.1200/po.18.00345